Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke "A2NTX"

Active, not recruiting

Phase 2/3 Results N/A

Summary of Purpose

To test the safety and efficacy of a new generation botulinum toxin preparation A2NTX for treating stroke patients with lower limb spasticity. - we study the degree of spasticity in the ankle and knee joints, and walking speed in 30 patients with stroke before and after injecting 300 units of BOTOX or A2NTX in a blinded manner as for the patient, the physician, and the examiner. - we also...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 January 2014.

1 Jul 2013 18 Jul 2013 1 Jan 2014 Unavailable 1 Jan 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment